ASN Report 2020

joint positions by the various members on given subjects and to propose directions for studies to be undertaken in order to clarify subjects that lack data or clarity. ASN also heads the national committee in charge of monitoring the National Plan for the management of radon risks. In 2019 and 2020, the Committee more specifically worked on preparing the results of the 3rd plan (2016-2019) and preparing the 4th radon plan for the period 2020-2024. The Committee met six times for this purpose (see chapter 1). Within the framework of this plan, ASN has since 2018 been in charge of a working group tasked with coordinating communications about management of the radon risk. 2.7  The other stakeholders As part of its mission to protect the general public from the health risks of ionising radiation, ASN cooperates closely with other institutional stakeholders with competence for health issues. 2.7.1 The National Agency for the Safety of Medication and Health Products The National Agency for the Safety of Medication and Health Products (ANSM) was created on 1 May 2012. The ANSM, a public institution reporting to the Ministry in charge of health, has taken up the functions of the French Health Products Safety Agency (Afssaps) alongside other new responsibilities. Its key role is to offer patients equitable access to innovation and to guarantee the safety of health products throughout their life cycle, from initial testing through to monitoring after receiving marketing authorisation. The Agency and its activities are presented on its website ansm.sante.fr . The ASN-ANSM convention was renewed on 27 June 2017. 2.7.2 French National Authority for Health The essential role of the French National Authority for Health (HAS), an independent administrative Authority created in 2004, is to maintain an equitable health system and improve the quality of patient care. The Authority and its activities are presented on its website has-sante.fr . An ASN-HAS agreement, signed on 4 December 2008, was renewed on 15 December 2015. An ASN- HAS action plan is appended to this agreement and is regularly updated. 2.7.3 French National Cancer Institute Created in 2004, the French National Cancer Institute (INCa) is primarily responsible for coordinating activities in the fight against cancer. The Institute and its activities are presented on its website e-cancer.fr . Regular discussions take place between the INCa and ASN. TABLE 2 Status and activities of the main civil nuclear safety regulators (*) COUNTRY/ REGULATORY AUTHORITY STATUS ACTIVITIES ADMINIS­ TRATION GOVERNMENT AGENCY INDEPEN­ DENT AGENCY SAFETYOF CIVIL INSTAL- LATIONS RADIATIONPROTECTION SECURITY (PROTECTION AGAINSTMALICIOUS ACTS) TRANSPORT SAFETY LARGE NUCLEAR FACILITIES EXCLUDING BNIs PATIENTS SOURCES NUCLEAR MATERIALS Europe Germany/BMUB + Länder ■ ■ ■ ■ ■ ■ ■ ■ Belgium/AFCN ■ ■ ■ ■ ■ ■ ■ ■ Spain/CSN ■ ■ ■ ■ ■ ■ ■ ■ Finland/STÜK ■ ■ ■ ■ ■ ■ ■ ■ France/ASN ■ ■ ■ ■ ■ ■ (**) ■ United Kingdom/ ONR ■ ■ ■ ■ ■ ■ Sweden/SSM ■ ■ ■ ■ ■ ■ ■ ■ Switzerland/ENSI ■ ■ ■ ■ ■ Other countries Canada/CCSN ■ ■ ■ ■ ■ ■ ■ ■ China/NNSA ■ ■ ■ ■ ■ ■ ■ Korea/NSSC ■ ■ ■ ■ ■ ■ ■ United States/ NRC ■ ■ ■ ■ ■ ■ ■ ■ (***) India/AERB ■ ■ ■ ■ ■ ■ ■ ■ Japan/NRA ■ ■ ■ ■ ■ ■ ■ ■ Russia/ Rostekhnadzor ■ ■ ■ ■ ■ ■ ■ Ukraine/SNRIU ■ ■ ■ ■ ■ ■ ■ ■ * Schematic, simplif ied representation of the main areas of competence of the entities (administration, independent agencies within Government or independent agencies outside government) responsible for regulating nuclear activities in the world’s nuclear countries. ** Responsibility for source security was given to ASN by the Ordinance of 10 February 2016. This provision came into force on 1 July 2017. *** National transports only. ASN Report on the state of nuclear safety and radiation protection in France in 2020 141 02 – THE PRINCIPLES OF NUCLEAR SAFETY AND RADIATION PROTECTION AND THE REGULATION AND OVERSIGHT STAKEHOLDERS 02